MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

SNP-Disease Association via a Comprehensive DNA Resource

Yissum Technology Transfer Company of the Hebrew University of Jerusalem
Provision of access to DNA samples of 16 common diseases to conduct association studies of specific single nucleotide polymorphisms (SNPs) and specific diseases

Full description

Function

  • Provision of access to DNA samples of 16 common diseases to conduct association studies of specific single nucleotide polymorphisms (SNPs) and specific diseases

Services provided

  • Access to  DNA samples from 16 common diseases: Type I diabetes, type II diabetes, asthma, colorectal cancer, breast cancer, prostate cancer, Alzheimer's disease, Parkinson's disease, multiple sclerosis, migraine, hypertension, coronary artery disease, schizophrenia, bipolar disorder, schizoaffective disorder, and rheumatoid arthritis
  • More than 500 samples per disease for most diseases and a common panel of 6000 healthy controls
  • Customers may request to genotype any number of SNPs on any number of samples (cases and controls)
  • Genotyping is performed in a central laboratory and included within the service (DNA is not shipped to customers)

Advantages

  • Family history, disease characterization, drug treatments, efficacy and adverse events, recorded in an electronic database. All samples were collected using strict and standardized clinical criteria from a homogeneous population
  • All samples were collected under the appropriate ethical guidelines including proper informed consent and approval of ethical committees (IRB)
  • All samples were collected in Israel from the Ashkenazi Jewish population significantly increasing the genetic and environmental homogeneity of the samples
  • Results belong solely to the customer
  • Completely confidential service

Licensing contact

Elena Canetti
VP
Marketing

Contact directly

Company details

Yissum Technology Transfer Company of the Hebrew University of Jerusalem

Yissum protects, promotes and markets the technologies and expertise of the University of Jerusalem

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us